Michel Slama

6.4k total citations · 2 hit papers
125 papers, 4.0k citations indexed

About

Michel Slama is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Michel Slama has authored 125 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Cardiology and Cardiovascular Medicine, 31 papers in Surgery and 31 papers in Molecular Biology. Recurrent topics in Michel Slama's work include Amyloidosis: Diagnosis, Treatment, Outcomes (29 papers), Cardiac Imaging and Diagnostics (22 papers) and Cardiac Valve Diseases and Treatments (16 papers). Michel Slama is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (29 papers), Cardiac Imaging and Diagnostics (22 papers) and Cardiac Valve Diseases and Treatments (16 papers). Michel Slama collaborates with scholars based in France, United States and Italy. Michel Slama's co-authors include David Adams, Teresa Coelho, Haruki Koike, Philippe Gabríel Steg, Patrick Henry, Dominique Le Guludec, Vincent Algalarrondo, Olivier Milleron, Dan Ruşinaru and Emmanuel Teíger and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Michel Slama

118 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis

2019 316 citations Scott D. Solomon, David Adams et al. Circulation profile →
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease

2019 288 citations David Adams, Haruki Koike et al. Nature Reviews Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michel Slama France	29	2.3k	1.5k	1.2k	636	394	125	4.0k
Elena Biagini Italy	35	3.8k 1.6×	968 0.6×	881 0.8×	842 1.3×	222 0.6×	170	4.8k
Patrick Collier United States	27	2.1k 0.9×	1.0k 0.7×	460 0.4×	639 1.0×	401 1.0×	106	3.2k
Andrea Barison Italy	34	2.9k 1.3×	789 0.5×	671 0.6×	1.1k 1.7×	216 0.5×	160	4.0k
Thomas A. Treibel United Kingdom	37	3.1k 1.4×	1.5k 1.0×	631 0.5×	1.8k 2.8×	676 1.7×	161	5.0k
Jonathan D. Marmur United States	35	2.0k 0.9×	644 0.4×	1.8k 1.5×	792 1.2×	134 0.3×	148	4.4k
Daniel Sado United Kingdom	27	2.4k 1.0×	692 0.5×	451 0.4×	1.6k 2.5×	319 0.8×	94	3.8k
Adam L. Dorfman United States	27	1.7k 0.7×	1.6k 1.0×	1000 0.9×	355 0.6×	132 0.3×	85	4.1k
Alicia M. Maceira Spain	21	2.8k 1.2×	577 0.4×	435 0.4×	1.6k 2.4×	285 0.7×	61	3.9k
Laurence Jesel France	33	2.0k 0.9×	1.2k 0.8×	504 0.4×	258 0.4×	75 0.2×	135	3.6k
Sabahat Bokhari United States	26	1.1k 0.5×	2.0k 1.3×	212 0.2×	801 1.3×	990 2.5×	80	3.4k

Countries citing papers authored by Michel Slama

Since Specialization

Citations

This map shows the geographic impact of Michel Slama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Slama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Slama more than expected).

Fields of papers citing papers by Michel Slama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Slama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Slama. The network helps show where Michel Slama may publish in the future.

Co-authorship network of co-authors of Michel Slama

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Slama. A scholar is included among the top collaborators of Michel Slama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Slama. Michel Slama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lévy, Bruno, Michel Slama, Inès Lakbar, et al.. (2024). Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review. Journal of Clinical Medicine. 13(10). 2951–2951. 5 indexed citations

Labeyrie, Céline, Cécile Cauquil, Bruno Francou, et al.. (2023). Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers. Journal of Neurology Neurosurgery & Psychiatry. 95(6). 489–499. 13 indexed citations

Socié, Pierre, Anouar Benmalek, Cécile Cauquil, et al.. (2023). Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosis. Amyloid. 30(3). 303–312. 7 indexed citations

Solomon, Scott D., David Adams, Arnt V. Kristen, et al.. (2019). Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis. Circulation. 139(4). 431–443. 316 indexed citations breakdown →

Adams, David, Haruki Koike, Michel Slama, & Teresa Coelho. (2019). Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nature Reviews Neurology. 15(7). 387–404. 288 indexed citations breakdown →

Théaudin, Marie, Pierre Lozeron, Vincent Algalarrondo, et al.. (2018). Upper limb onset of hereditary transthyretin amyloidosis is common in non‐endemic areas. European Journal of Neurology. 26(3). 497–497. 20 indexed citations

Malbrain, Manu L. N. G., Brecht De Tavernier, Michel Slama, et al.. (2017). Executive summary on the use of ultrasound in the critically ill: Consensus report from the 3rd Course on Acute Care Ultrasound (CACU). HAL (Le Centre pour la Communication Scientifique Directe). 13 indexed citations

Gaspard, Nicolas, et al.. (2017). Semantic Dementia and Motor Neuron Disease: Case Confirmation of TDP43 Pathology Associated with a Predominant Right Temporal Atrophy. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 6(3). 146–152. 1 indexed citations

Adams, David, Marie Théaudin, Cécile Cauquil, Vincent Algalarrondo, & Michel Slama. (2014). FAP Neuropathy and Emerging Treatments. Current Neurology and Neuroscience Reports. 14(3). 435–435. 55 indexed citations

10.

Antonini, Térésa, Pierre Lozeron, C. Lacroix, et al.. (2013). Reversibility of Acquired Amyloid Polyneuropathy After Liver Retransplantation. American Journal of Transplantation. 13(10). 2734–2738. 16 indexed citations

11.

Adams, David, Didier Samuel, & Michel Slama. (2012). Traitement des neuropathies amyloïdes héréditaires. La Presse Médicale. 41(9). 793–806. 7 indexed citations

12.

Mary‐Krause, Murielle, Emmanuel Teíger, Sylvie Lang, et al.. (2012). 023 HIV-infected status is associated with increased recurrence of acute coronary syndrome. Results of long term follow up of the PACS-HIV study. Archives of Cardiovascular Diseases Supplements. 4(1). 8–8. 1 indexed citations

13.

Boccara, Franck, Murielle Mary‐Krause, Emmanuel Teíger, et al.. (2011). Abstract 15792: HIV-Infected Patients Have an Increased Risk of Recurrent Ischemic Events as Compared to the General Population After an Acute Coronary Syndrome. Circulation. 124. 1 indexed citations

14.

Boccara, Franck, Murielle Mary‐Krause, Emmanuel Teíger, et al.. (2010). Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. European Heart Journal. 32(1). 41–50. 81 indexed citations

15.

Dinanian, S., Christophe Boixel, Jean‐Sébastien Hulot, et al.. (2008). Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation. European Heart Journal. 29(9). 1190–1197. 48 indexed citations

16.

Tribouilloy, C, Dan Ruşinaru, Haïfa Mahjoub, et al.. (2007). Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. European Heart Journal. 29(3). 339–347. 324 indexed citations

17.

Montalescot, Gilles, Georges Sideris, Catherine Meuleman, et al.. (2006). A Randomized Comparison of High Clopidogrel Loading Doses in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes. Journal of the American College of Cardiology. 48(5). 931–938. 381 indexed citations

18.

Delahaye, Nicolas, S. Dinanian, Michel Slama, et al.. (1999). Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. European Journal of Nuclear Medicine and Molecular Imaging. 26(4). 416–424. 56 indexed citations

19.

Thomas, Olivier, Antoine Leenhardt, C Masquet, et al.. (1994). [Pericardial constriction caused by epicardial patches of automatic implantable defibrillators. Apropos of 3 cases].. PubMed. 87(7). 931–5. 1 indexed citations

20.

Slama, Michel, Dominique Le Guludec, Antoine Leenhardt, et al.. (1991). Complete Atrioventricular Block Following Mediastinal Irradiation: A Report of Six Cases. Pacing and Clinical Electrophysiology. 14(7). 1112–1118. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact